Blog | Genomic Testing Cooperative

Genomic Testing Cooperative to Present data at the American Society of Hematology Meeting on its Proprietary Machine Learning Approaches for RNA Transcriptome Data and on the Use of Liquid Biopsy

Irvine, California– December 1, 2021 – Genomic Testing Cooperative, LCA (GTC) announced that it will be presenting at the annual American Society of Hematology (ASH) meeting new data on the use of their proprietary machine learning approaches in the diagnosis of acute graft-versus-host disease (aGVHD) and for the stratifying of patients with diffuse large B-cell […]

GTC at ASH 2021

GTC is excited to be exhibiting at ASH for the first time and look forward to meeting people in person. Our booth # 3440 and would like you will stop by and say hello. If you would like to schedule a meeting fill out the form below We have four abstracts being presented at ASH – here is […]

Genomic Testing Cooperative Announces Collaboration with Elevation Oncology to Expand Comprehensive Genomic Testing for NRG1 Fusions Across Solid Tumors in Support of the Phase 2 CRESTONE Study

Irvine, CA – June 30th – Genomic Testing Cooperative, a first-in-class diagnostic company based on a cooperative business model (Co-Op) using the most recent advances in NGS technology, announced today a collaboration with Elevation Oncology to enhance identification of patients with any solid tumor harboring an NRG1 fusion who may be eligible for enrollment in […]

Irvine, California– June 23, 2021 – Genomic Testing Cooperative, LCA (GTC) announced that the New York State Clinical Evaluation Program (CLEP) has completed their evaluation and approved all GTC’s Next Generation Sequencing (NGS) profiling tests for hematologic neoplasms and solid tumors. This includes: -GTC Hematology Profile (177 genes)-GTC Hematology Fusion/Expression (1408 genes)-GTC Hematology PLUS (177 […]

John Theurer Cancer Center Patients Now Have Access to State-of-the-Art Genomic Profiling Laboratory Technology

New on-site laboratory called Key Genomics is a partnership between Regional Cancer Care Associates (RCCA) and Genomic Testing Cooperative (GTC), provides more precise testing to help improve cancer patient outcomes HACKENSACK, N.J. AND IRVINE, C.A., May 4, 2021 —Patients at John Theurer Cancer Center at Hackensack University Medical Center now have access to state-of-the-art genomic […]

EDISON, N.J. AND IRVINE, C.A. (March 16, 2021) — Hackensack Meridian Health and Genomic Testing Cooperative (GTC) in Irvine, California, have teamed up to establish the first-of-its-kind genomic profiling laboratory called Anthology Diagnostics, to generate more personalized, precise, and real-time insights for cancer patients, oncologists and hospitals. The reference laboratory located at Hackensack Meridian JFK University Medical […]

Irvine, California – February 2, 2021 – Genomic Testing Cooperative, LCA (GTC) announced today that they are establishing a program offering comprehensive molecular profiling (DNA+RNA) testing to patients with cancer who are affected by cancer disparity and unable to pay due to lack of insurance or lack of coverage of this type of testing. Ethnic and […]

GTC scientists contribute to major study published in Journal of Clinical Oncology: Prediction of outcome in CLL patients

GTC scientists collaborate with the NIH on a study just published in the Journal of Clinical Oncology. The publication is titled: Prediction of outcome in CLL patients treated with ibrutinib: development and validation of a four-factor prognostic model. You can read the article here (subscription required). Abstract: PURPOSE Randomized trials established the superiority of ibrutinib-based […]

Jul 23, 2020 | John Gilmore NEW YORK – As part of plans to establish a country-wide network of labs for minimizing the cost of sequencing, Genomic Testing Cooperative (GTC) has launched a joint venture with Hackensack Meridian Health (HMH) that will analyze clinical samples from patients with a variety of different cancers. The Irvine, […]

Utilize the first AI software for diagnosing DLBCL

GTC is the first and only diagnostic lab to deploy true artificial intelligence (AI) software for classifications of lymphoma. Do not accept partial results, send your lymphoma to GTC for comprehensive classification using RNA/DNA and artificial intelligence. Get results in 7 days for DNA and 10 days for RNA GTC was recently published in Blood […]

Innovation in Next Generation Sequencing

Making Genomics Available and Affordable for Everyone

Genomic Testing Cooperative to Present data at the American Society of Hematology Meeting on its Proprietary Machine Learning Approaches for RNA Transcriptome Data and on the Use of Liquid Biopsy

GTC at ASH 2021

Genomic Testing Cooperative Announces Collaboration with Elevation Oncology to Expand Comprehensive Genomic Testing for NRG1 Fusions Across Solid Tumors in Support of the Phase 2 CRESTONE Study

Genomic Testing Cooperative Completes New York State Approval and Medicare (Palmetto) Coverage for all DNA and RNA Tests Offered for Molecular Profiling of Hematologic and Solid Tumors

John Theurer Cancer Center Patients Now Have Access to State-of-the-Art Genomic Profiling Laboratory Technology

Hackensack Meridian Health Launches Anthology Diagnostics Laboratories for State-of-the-Art Lab Genomic Profiling of Cancers

Genomic Testing Cooperative Establishes a Program to Address Cancer Disparity by Offering Molecular Profiling to Minority Patients without Adequate Insurance Coverage and Facilitating Access to Precision Medicine and Enrollment in Clinical Trials

GTC scientists contribute to major study published in Journal of Clinical Oncology: Prediction of outcome in CLL patients

Genomic Testing Cooperative Aims to Expand Clinical, Commercial NGS Access With Co-Op Model

Utilize the first AI software for diagnosing DLBCL